.On the heels of an FDA rejection for its own chief rival Novo Nordisk, Eli Lilly is actually pullin...
.Merely a handful of months after dosing the initial client in a stage 2 test for recently diagnosed...
.Eli Lilly's hunt for weight problems targets has led it to the dark genome. The Big Pharma has actu...
.Collection Biosciences is carrying on up. The tissue therapy business has actually added $325 milli...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...
.Aelis Farma's chances of securing a fast, good choice on a $one hundred thousand choice settlement ...
.ProKidney has stopped among a pair of phase 3 tests for its tissue therapy for renal ailment after ...
.Vaxcyte introduced what analysts named "spectacular" phase 1/2 records for its own 31-valent pneumo...
.Recursion has stumbled with a very early exam of its own tech-enabled strategy to medication explor...
.Contact it a situation of really good chemistry: Acepodia, a biotech based on Nobel Champion scient...